U.S. Study Shows Significant Improvement for Patients Suffering from Excessive Sweating with Topical Anti... ( ALBANY N.Y. May 15 /- Valeo ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

U.S. Study Shows Significant Improvement for Patients Suffering from Excessive Sweating with Topical Antiperspirant

Date:5/15/2009

ALBANY, N.Y., May 15 /PRNewswire/ -- Valeo Pharma announced today a new study recently published that demonstrated the efficacy and safety of Hydrosal(R), a novel high strength topical antiperspirant with 15% aluminum chloride and 2% salicylic acid in proprietary gel base for patients with moderate-to-severe hyperhidrosis (excessive sweating).

The study, conducted by Katherine Flanagan, MD and Dee Anna Glaser, MD at the Department of Dermatology at Saint Louis University School of Medicine, was published in the May issue of the Journal of Drugs in Dermatology (JDD). Of the thirty patients who were enrolled, 43% had tried high-strength antiperspirants previously. Patients were given Hydrosal and monitored at 4 and 12 weeks for efficacy and tolerability. They were instructed to apply a small amount of the gel at bedtime for seven days and twice per week or as tolerated thereafter.

Overall, 70% of participants demonstrated significant improvement with satisfaction of treatment and Hydrosal was well-tolerated with minimal side effects. Patients who had previously failed other high-strength antiperspirants also reported similar success. They also experienced significant improvements in quality of life including improvement in social and professional situations.

"The key to Hydrosal's effectiveness is the gel base -- it is unique and helps balance high efficacy and tolerability for patients with moderate to severe hyperhidrosis. Valeo is extremely pleased that these results have shown a significant improvement in the quality of life for these patients, so they can enjoy activities more and not have to worry about their excessive sweating," stated Steve Saviuk, President of Valeo Pharma.

To learn more about Hydrosal Professional, please visit www.hydrosalpro.com or contact Valeo Pharma at 866 694-0150. <
'/>"/>

SOURCE Valeo Pharma
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks

Post Your Comments:

Breaking Medicine News(10 mins):Health News:Approval of Michigan Smoke-Free Legislation is Historic Win for Health 2 Health News:Approval of Michigan Smoke-Free Legislation is Historic Win for Health 3 Health News:Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting 2 Health News:Weight Watchers Declares Quarterly Dividend 2 Health News:Most Hospital Patients Don't Know What Meds They're Taking 2 Health News:Most Hospital Patients Don't Know What Meds They're Taking 3

[1] Approval of Michigan Smoke-Free Legislation is Historic Win for Health [0] University of Maryland chemist receives Astellas Award for blindness prevention research [1] Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting [0] Weight Watchers Declares Quarterly Dividend [0] Most Hospital Patients Don't Know What Meds They're Taking

'Know Your L-Dex(TM)' (Lymphedema Index) Awareness Campaign Attracts Large Numbers of Breast Cancer Survivors at Komen Race for the Cure(R) Events Results From Pre-Election Surveys Published in NEJM Show Deep Concerns About State of Health Care With McCain and Obama Supporters Differing Sharply on Directions for New Administration 'The Age Factor' on the Campaign Trail: When the Going Gets Tough, the Tough Keep Moving HLTH Corporation Announces Third Quarter Financial Results K-State and Kansas Health Foundation Team Up to Promote 'One Health Kansas'Nuvelo Reports Third Quarter 2008 Financial Results

Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2 Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2 New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2 New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3 New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4 Retirement Brings Most a Big Health Boost 60954 1 Retirement Brings Most a Big Health Boost 60954 2 Retirement Brings Most a Big Health Boost 60954 3 Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin 60950 1 Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin 60950 2 Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 6075 1 Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 6075 2 Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 6075 3

[0] Dynatronics Receives 180-Day NASDAQ Extension [0] Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline [0] New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals

Other Medicine Technology:Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 2 Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 3 Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 4 Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 2 Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 3 Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 4 Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 5 Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 6 Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 7

Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel

Medicine Products:

Unitized Electric Micro-Drill, Throttleless Unitized Electric Reciprocating Saw, Throttleless Brasseler USA™ Battery Tester Brasseler USA™ STR-3000 Battery Pack

U.S. Study Shows Significant Improvement for Patients Suffering from Excessive Sweating with Topical Anti...( ALBANY N.Y. May 15 /- Valeo ...),Health